Daily Signals
2482 companies scored · 2026-10-14 run in progress: 3417 of ~5379 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D
Distribution of the day's forecasts
30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
287 companies
Sorted by market cap ↓ · forecast rankings are part of the paid plans
| Ticker | Rating | 30D | Δ | |
|---|---|---|---|---|
| MYGNMYRIAD GENETICS INC | Unlock rating and forecasts | |||
| CANFCan-Fite BioPharma Ltd. | +1.04% | ▼ 1 | ||
| EDITEditas Medicine, Inc. | Unlock rating and forecasts | |||
| GALTGALECTIN THERAPEUTICS INC | +1.06% | · | ||
| RLMDRELMADA THERAPEUTICS, INC. | Unlock rating and forecasts | |||
| ENTAENANTA PHARMACEUTICALS INC | +1.08% | · | ||
| FENCFENNEC PHARMACEUTICALS INC. | Unlock rating and forecasts | |||
| KYTXKyverna Therapeutics, Inc. | Unlock rating and forecasts | |||
| EBSEmergent BioSolutions Inc. | Unlock rating and forecasts | |||
| NBPNovaBridge Biosciences | +1.04% | · | ||
| CCCCC4 Therapeutics, Inc. | Unlock rating and forecasts | |||
| ARCTArcturus Therapeutics Holdings Inc. | Unlock rating and forecasts | |||
| TTRXTurn Therapeutics Inc. | Unlock rating and forecasts | |||
| CGCCanopy Growth Corp | +0.88% | · | ||
| AGENAGENUS INC | Unlock rating and forecasts | |||
| ARTVArtiva Biotherapeutics, Inc. | Unlock rating and forecasts | |||
| CYPHCYPHERPUNK TECHNOLOGIES INC. | Unlock rating and forecasts | |||
| OCGNOcugen, Inc. | Unlock rating and forecasts | |||
| CABACabaletta Bio, Inc. | Unlock rating and forecasts | |||
| USNAUSANA HEALTH SCIENCES INC | +0.73% | ▲ 1 | ||
| NWBONORTHWEST BIOTHERAPEUTICS INC | +0.78% | · | ||
| SRZNSurrozen, Inc./DE | Unlock rating and forecasts | |||
| ELTPELITE PHARMACEUTICALS INC /NV/ | +1.06% | · | ||
| VNDAVanda Pharmaceuticals Inc. | +1.08% | · | ||
| CATXPerspective Therapeutics, Inc. | Unlock rating and forecasts | |||
| LABSTANDARD BIOTOOLS INC. | +0.85% | · | ||
| ABEOABEONA THERAPEUTICS INC. | Unlock rating and forecasts | |||
| BIOABioAge Labs, Inc. | Unlock rating and forecasts | |||
| MREOMereo BioPharma Group plc | Unlock rating and forecasts | |||
| RCKTROCKET PHARMACEUTICALS, INC. | Unlock rating and forecasts | |||
| IPSCCentury Therapeutics, Inc. | Unlock rating and forecasts | |||
| IKTInhibikase Therapeutics, Inc. | Unlock rating and forecasts | |||
| SABSSAB Biotherapeutics, Inc. | Unlock rating and forecasts | |||
| LFCRLIFECORE BIOMEDICAL, INC. \DE\ | +0.93% | · | ||
| QTTBQ32 Bio Inc. | Unlock rating and forecasts | |||
| FATEFATE THERAPEUTICS INC | Unlock rating and forecasts | |||
| IMRXImmuneering Corp | Unlock rating and forecasts | |||
| GLSIGreenwich LifeSciences, Inc. | Unlock rating and forecasts | |||
| LXEOLexeo Therapeutics, Inc. | Unlock rating and forecasts | |||
| NATRNATURES SUNSHINE PRODUCTS INC | +0.97% | · | ||
| KROSKeros Therapeutics, Inc. | Unlock rating and forecasts | |||
| SIGASIGA TECHNOLOGIES INC | +1.04% | · | ||
| MGNXMACROGENICS INC | Unlock rating and forecasts | |||
| ADCTADC Therapeutics SA | Unlock rating and forecasts | |||
| AKBAAkebia Therapeutics, Inc. | Unlock rating and forecasts | |||
| ALECAlector, Inc. | Unlock rating and forecasts | |||
| NAGENiagen Bioscience, Inc. | Unlock rating and forecasts | |||
| RNACCartesian Therapeutics, Inc. | Unlock rating and forecasts | |||
| SIONSionna Therapeutics, Inc. | Unlock rating and forecasts | |||
| UPBUpstream Bio, Inc. | Unlock rating and forecasts | |||
By sector
Median 30D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.